Salcaprozate Sodium

ExcipientCAS 203787-91-1UNII 1YTW0422YU

30 organisations hold 31 active FDA Type IV Drug Master Files for Salcaprozate Sodium.

Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology

Active Type IV DMFs (31)

HolderDMFFiled asSubmitted
CHANGZHOU SUNLIGHT PHARMACEUTICAL CO LTD44368SALCAPROZATE SODIUMSept 2026
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
China
43393SALCAPROZATE SODIUMJun 2026
ZHEJIANG AUSUN PHARMACEUTICAL CO LTD
China
44148SALCAPROZATE SODIUMJun 2026
PHARMSYN CO LTD43222SALCAPROZATE SODIUM (SNAC)Apr 2026
SOLARA ACTIVE PHARMA SCIENCES LTD
India
43784SALCAPROZATE SODIUMApr 2026
MICRO LABS LTD
India
42780SALCAPROZATE SODIUMApr 2026
HEFEI TIANRUI PHARMACEUTICAL CHEMICAL CO LTD
China
43961SALCAPROZATE SODIUM - PROCESS IIMar 2026
MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTD43745SALCAPROZATE SODIUMMar 2026
Alembic Pharmaceuticals Limited
India
43625SALCAPROZATE SODIUMFeb 2026
HONOUR LAB LTD
India
40329SALCAPROZATE SODIUMFeb 2026
CHANGZHOU PHARMACEUTICAL FACTORY
China
43294SALCAPROZATE SODIUMDec 2025
OLON SPA
Italy
43008SALCAPROZATE SODIUMDec 2025
ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO LTD
China
42303SALCAPROZATE SODIUMAug 2025
NANJING ABYDOS PHARMA TECHNOLOGY CO LTD42103SALCAPROZATE SODIUMJul 2025
Chongqing Sintaho Pharmaceutical Co., Ltd.
China
41721SALCAPROZATE SODIUMApr 2025
ALLSINO PHARMACEUTICAL CO LTD
China
41615SALCAPROZATE SODIUMMar 2025
EAGLE CHEMICAL WORKS41533SALCAPROZATE SODIUMMar 2025
AMI LIFESCIENCES PRIVATE LTD
India
40707SALCAPROZATE SODIUMNov 2024
QIDONG DONGYUE PHARMACEUTICAL CO LTD
China
40767SALCAPROZATE SODIUMNov 2024
Cipla Limited
India
39618SALCAPROZATE SODIUMOct 2024
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED
India
40217SALCAPROZATE SODIUMJul 2024
CHONGQING BIOLAND PHARMACEUTICAL LTD
China
40177SALCAPROZATE SODIUMJul 2024
ANHUI BEIRUI PHARMACEUTICAL TECHNOLOGY CO LTD40147SALCAPROZATE SODIUMJun 2024
XIAMEN SINOPEG BIOTECH CO LTD
China
40072SALCAPROZATE SODIUM (SNAC)Jun 2024
ANHUI POLY PHARM CO LTD
China
39651SALCAPROZATE SODIUMMar 2024
SICHUAN PUKANG PHARMACEUTICAL CO LTD39196SALCAPROZATE SODIUMNov 2023
Dr. Reddy's Laboratories Ltd.
India
38202SALCAPROZATE SODIUMMar 2023
MATRIX PHARMACORP PRIVATE LTD
India
37682SALCAPROZATE SODIUMDec 2022
HEFEI TIANRUI PHARMACEUTICAL CHEMICAL CO LTD
China
37135SALCAPROZATE SODIUMMay 2022
NAVINTA LLC
United States
36388SALCAPROZATE SODIUMOct 2021
MAITHRI LABORATORIES PRIVATE LTD
India
35672SALCAPROZATE SODIUMMar 2021

“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.

What these records establish

  • A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
  • Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
  • The holder is the organisation that filed. It is usually, but not always, the manufacturer.
  • Many excipients are supplied without any DMF, so this list is not every supplier of Salcaprozate Sodium.

How to qualify an excipient supplier

For suppliers

Do you supply Salcaprozate Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.